These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30659809)

  • 1. Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.
    Baumgartner C; de Kouchkovsky I; Whitaker E; Fang MC
    Am J Med; 2019 Jun; 132(6):722-732.e7. PubMed ID: 30659809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
    Siegal D; Yudin J; Kaatz S; Douketis JD; Lim W; Spyropoulos AC
    Circulation; 2012 Sep; 126(13):1630-9. PubMed ID: 22912386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials.
    Wang W; Su Y; Wu C; Sun Y; Dai N; Chen W; Zhang J; Xu Y; Brindis RG; Xu D; Li J
    BMC Cardiovasc Disord; 2020 Feb; 20(1):53. PubMed ID: 32013892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy.
    Spyropoulos AC; Bauersachs RM; Omran H; Cohen M
    Curr Med Res Opin; 2006 Jun; 22(6):1109-22. PubMed ID: 16846544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic and bleeding risk of periprocedural bridging anticoagulation: A systematic review and meta-analysis.
    Kuo HC; Liu FL; Chen JT; Cherng YG; Tam KW; Tai YH
    Clin Cardiol; 2020 May; 43(5):441-449. PubMed ID: 31944351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of bridging with low molecular weight heparins: a systematic review and partial meta-analysis.
    Eijgenraam P; ten Cate H; Ten Cate-Hoek A
    Curr Pharm Des; 2013; 19(22):4014-23. PubMed ID: 23228321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.
    Chai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Zdraveska M; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M;
    Am J Med; 2018 Apr; 131(4):430-437. PubMed ID: 29274307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
    Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Barba M; Rohilla S; Terrenato I; Sperati F; Muti P; Schünemann HJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006650. PubMed ID: 18425959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
    Mar PL; Familtsev D; Ezekowitz MD; Lakkireddy D; Gopinathannair R
    Int J Cardiol; 2016 Jan; 202():578-85. PubMed ID: 26447666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Labedi N; Barba M; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006650. PubMed ID: 21678361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis.
    Castellucci LA; Cameron C; Le Gal G; Rodger MA; Coyle D; Wells PS; Clifford T; Gandara E; Wells G; Carrier M
    JAMA; 2014 Sep; 312(11):1122-35. PubMed ID: 25226478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging anticoagulation in patients treated with vitamin K antagonists prior to trochanteric and hip fracture surgeries: The current practice.
    Szklanny K; Jakubek M; Zbierska-Rubinkiewicz K; Undas A
    Adv Clin Exp Med; 2019 Apr; 28(4):469-477. PubMed ID: 30088350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural anticoagulation management of patients with venous thromboembolism.
    McBane RD; Wysokinski WE; Daniels PR; Litin SC; Slusser J; Hodge DO; Dowling NF; Heit JA
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):442-8. PubMed ID: 20139361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation for people with cancer and central venous catheters.
    Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.